increased anxiety on glp 1 causing GLP-1s linked to lower rates of and depression than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement GLP-1 medications used to treat

COPPER DYSREGULATION RELATED TO ATP7B GENETIC ISSUES IN WILSON DISEASE Excessive hepatic copper deposition in Wilson disease results from impaired biliary excretion of excess copper due to dysfunction of the ATP7B gene [20,21,24,27]

Try to keep from touching your face as much as possible to keep bacteria from getting into the micro-channels

This is your countdown clock

The FDA approved Foundayo (orforglipron) in April 2026 as the first oral GLP-1 weight loss medication that can be taken with food at any time of day

The smaller the liposomes, the easier and quicker they can be absorbed, allowing for greater delivery of the desired supplement

Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis